Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2017-04-28 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
2017年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2017 First Quarter Report" of 江苏四环生物股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as revenue, net profit, cash flow, assets, liabilities, and shareholder information for the first quarter of 2017. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year confirms it is an Interim / Quarterly Report. The document length (7470 characters) and content confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2017
2017-04-28 Chinese
2016年度监事会工作报告
Board/Management Information Classification · 90% confidence The document is titled as the "2016年度监事会工作报告" which translates to "2016 Supervisory Board Work Report". It details the supervisory board's activities, meetings, opinions on company operations, financial oversight, internal controls, and compliance with laws and regulations during the 2016 fiscal year. The content is a formal report from the supervisory board rather than an announcement or a brief summary. It includes substantive oversight and governance information but is not a full annual report or audit report by itself. Given the nature of the document as a supervisory board work report, it aligns best with the category of Board/Management Information (MANG), which covers announcements and reports related to company board activities and management oversight. The document length is 2001 characters, which is short but contains detailed supervisory content rather than just an announcement or certification. Therefore, the classification is MANG with high confidence.
2017-04-28 Chinese
2017年第一季度业绩预告
Earnings Release Classification · 95% confidence The document is titled as a '2017 First Quarter Performance Forecast' and provides estimated financial results for the period January 1 to March 31, 2017. It explicitly states that the forecast is unaudited and preliminary, with actual data to be confirmed in the official quarterly report. The document is short (700 characters) and serves as an announcement of expected financial performance rather than a full financial report containing actual financial statements or detailed analysis. Therefore, it is best classified as an Earnings Release (ER), which covers initial announcements of quarterly or periodical financial results with key highlights only. Q1 2017
2017-04-14 Chinese
2016年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a "2016年度业绩快报" which translates to "2016 Annual Performance Express Report" or "Performance Brief." It contains preliminary financial data for the year 2016, including revenue, profit, net assets, and earnings per share, with comparisons to the previous year. The document explicitly states that the data are preliminary and that the full annual report will be published later. The length of the document is 1482 characters, which is relatively short and consistent with a brief financial summary rather than a full annual report. It also includes a note that the full annual report will be released through official channels later. This type of document is typically an Earnings Release (ER) or a Performance Brief, but since it contains key financial highlights for the full year and is a preliminary announcement rather than the full detailed annual report (10-K), it fits best as an Earnings Release (ER). FY 2016
2017-04-14 Chinese
关于子公司股权置换的进展公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the progress of a subsidiary equity swap transaction. It mentions a board meeting approving the swap and completion of the equity delivery and new business licenses. The document length is only 422 characters, indicating it is a brief announcement rather than a detailed report. It does not contain financial statements or detailed analysis. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as equity swaps.
2017-01-25 Chinese
第八届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the first meeting of the eighth board of directors of Jiangsu Sihuan Bio-Pharmaceutical Co., Ltd. It details the election and appointment of board members and senior management positions, including chairman, general manager, financial director, board secretary, and deputy general managers. It also discusses the composition of board committees. The document includes voting results and reasons for opposition by some directors. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes and appointments in the company's board and senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is not a report publication announcement or certification. Hence, the classification is MANG with high confidence.
2017-01-19 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.